Xiangqin Weng
State Key Laboratory Of Medical Genomics
Shanghai, 200025, China
Shanghai, 200025, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Mutant p53 reactivation and DNA demethylation in the treatment of AML/MDS.
Journal: Science translational medicine
Published: August 12, 2026
Concurrent BCR::ABL1 and CBFA2T3::GLIS2 fusions in an adult patient with acute leukaemia.
Journal: The Lancet. Haematology
Published: March 13, 2026
Differential Prognosis and Transplant Strategies in CBF-AML With RUNX1::RUNX1T1 Versus CBFβ::MYH11 Fusions.
Journal: American journal of hematology
Published: October 05, 2025
KMT2A alterations in acute myeloid leukemia: a proposed genetic risk model and transplantation outcomes.
Journal: Experimental hematology & oncology
Published: July 09, 2025
MRD and NK-Cell Chimerism Predict Transplant Outcomes in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Journal: American journal of hematology
Published: February 14, 2025
RIG-I-Inducing Small Molecules Potently Inhibit HMA-Resistant AML Through Igniting the Overloaded dsRNA Arsenal.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 07, 2024
Single-cell multiomics reveals a gene regulatory circuit driving leukemia cell differentiation.
Journal: Oncogene
Published: September 20, 2024
Efficacy and safety of olverembatinib in adult BCR::ABL1-positive ALL with T315I mutation or relapsed/refractory disease.
Journal: British journal of haematology
Published: June 11, 2024
Chinese expert consensus on flow cytometric detection of hematological malignant cells in tissue samples.
Journal: Journal of the National Cancer Center
Published: April 02, 2024
Refined risk stratification helps guiding transplantation choice in adult BCR::ABL1-positive acute lymphoblastic leukemia.
Journal: Blood cancer journal
Published: February 20, 2024
Last Updated: 09/26/2026